Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the investors / analysts meet held on November 14, 2022 to discuss the Company's un-audited financial results for the quarter and period ended September 30, 2022 is available on the website of the Company i.e. https://www.fortishealthcare.com/investors.
14-11-2022
Bigul

Acquisition of Fortis was transformational for IHH in India, says Dr Kelvin Loh, MD and CEO

 Disappointing that Daiichi targeted coming after Fortis while in trying to redress their claims against former promoters: Fortis Chairman
14-11-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper publication dated November 12, 2022 in the columns of English daily 'Financial Express', all editions and Punjabi daily 'Rozana Spokesman', Mohali edition, with respect to un-audited financial results of the Company for the quarter and period ended on September 30, 2022.
12-11-2022

Fortis Healthcare Q2 profit rises 67% to Rs 218 crore

 Its Q2FY23 hospital business revenues were at Rs 1,297 crore versus Rs 1,098.5 crore in Q2FY22.
11-11-2022

Ready to proceed with Fortis open offer after Sebi's nod: IHH Healthcare

 Malaysia's IHH Healthcare on Friday said it is ready to proceed with its stalled open offer for 26.1 per cent stake in Fortis once capital markets regulator SEBI gives it a go-ahead. The company, which currently is the largest shareholder in Fortis with a 31.17 per cent stake, said it remains fully committed to Fortis and India. "We certainly understand the frustration Fortis investors have felt over the past four years around the uncertainty of the IHH open offer. With the recent Supreme Court judgement ruling making clear that we have conducted our investment into Fortis in a fair and transparent manner, we are discussing with Securities and Exchange Board of India (SEBI) to move ahead with the offer," IHH Healthcare Managing Director and CEO Kelvin Loh said in a statement. Should they concur and approve, IHH is ready to proceed with the open offer as soon as possible, he added. Loh said Fortis is IHH's key growth platform in India. "We are hopeful for a positive outcome so that
11-11-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 This is in continuation to our letter dated September 22, 2022 and September 23, 2022, kindly find attached herewith announcement made by IHH Healthcare Berhad dated November 11, 2022 on Malaysian Stock Exchange (i.e. Bursa Malaysia) with respect to pending Open Offer of the Company and Fortis Malar Hospitals Limited. We will keep the stock exchanges updated / informed regarding material development in this matter.
11-11-2022
Bigul

Q2FY23 Quarterly Result Announced for Fortis Healthcare Ltd.

 Fortis Healthcare announced Q2FY23 results: Consolidated revenues for Q2FY23 at Rs 1,607 crore, up 9.9% EBITDA at Rs 319 crore, 19.8% margin vs 20.0% in Q2FY22 PBT prior to exceptional items at Rs 216 crore versus Rs 182 crore in Q2FY22 PAT at Rs 218 crore versus Rs 131 crore in Q2FY22 Ravi Rajagopal, Chairman, Board of Directors, Fortis Healthcare, stated, “Our Q2FY23 consolidated results reflect the robust performance of our hospital business that now contributes ~77% to our consolidated EBITDA and has seen healthy margins expansion. The hospital business performance has enabled us to maintain our consolidated margins at around 20% despite covid volumes significantly impacting the diagnostics business. I’m also pleased that for the first time ever, SRL, our majority 57% held diagnostics subsidiary has declared a dividend. This shows our commitment towards efforts on augmenting shareholder returns and reflects the growing confidence we have in our future expansion and growth prospects. Our brownfield expansion plans in facilities like Mulund, BG Road and Anandpur are progressing well. Simultaneously, digital transformation efforts such as implementation of Electronic Medical Records (EMR), ERP implementation and improving patient experience through websites and apps are being worked upon. EMR implementation specifically, would significantly enhance patient care allowing quick access to healthcare records and faster diagnosis and treatment. Portfolio rationalisation coupled with a well chalked out inorganic expansion strategy focusing on our key existing clusters will further drive our operational performance.” Result PDF
11-11-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Outcome Of The Board Meeting And Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. November 11, 2022, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the qua1ter and period ended on September 30, 2022. Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for the qua1ter and period ended on September 30, 2022. Fu1ther, a copy of the press release and investor presentation being issued in this regard is also enclosed. * The meeting commenced at 0900 Hours 1ST and concluded at 1800 Hours 1ST.
11-11-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Board Meeting Outcome for Outcome Of The Board Meeting And Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. November 11, 2022, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the qua1ter and period ended on September 30, 2022. Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for the qua1ter and period ended on September 30, 2022. Fu1ther, a copy of the press release and investor presentation being issued in this regard is also enclosed. * The meeting commenced at 0900 Hours 1ST and concluded at 1800 Hours 1ST.
11-11-2022

Time has passed when offer price of Rs 170 for a share was good: IHH's Loh

 Will start rebranding Fortis as Parkway shortly: Fortis chairman Ravi Rajagopal
10-11-2022
Next Page
Close

Let's Open Free Demat Account